Arizona Telemedicine Program Southwest Telehealth Resource Center Artificial Intelligences Virtual nursing assistants Population health management Automated health records Remote patient monitoring.
Parents and pediatric oncology experts share strategies to help parents cope with a diagnosis of childhood cancer, make treatment-related decisions, support their child and family, and manage cancer information in NCI’s Childhood Cancer Video Series.
We are beginning to roll out new voice and image capabilities in ChatGPT. They offer a new, more intuitive type of interface by allowing you to have a voice conversation or show ChatGPT what you’re talking about.
Voice and image give you more ways to use ChatGPT in your life. Snap a picture of a landmark while traveling and have a live conversation about what’s interesting about it. When you’re home, snap pictures of your fridge and pantry to figure out what’s for dinner (and ask follow up questions for a step by step recipe). After dinner, help your child with a math problem by taking a photo, circling the problem set, and having it share hints with both of you.
We’re rolling out voice and images in ChatGPT to Plus and Enterprise users over the next two weeks. Voice is coming on iOS and Android (opt-in in your settings) and images will be available on all platforms.
When a Child Has Cancer
Posted in biotech/medical
Parents and pediatric oncology experts share strategies to help parents cope with a diagnosis of childhood cancer, make treatment-related decisions, support…
Studies of a “future-proof” vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals. The studies suggest that a single vaccine with combinations of these antigens—a substance that causes the immune system to produce antibodies against it—could protect against an even greater range of current and future coronaviruses.
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2—the virus that causes COVID-19—as well as other major coronaviruses, including those that caused the first SARS epidemic in 2002.
The studies in mice, rabbits and guinea pigs—an important step before beginning human clinical trials, currently underway in Southampton and Cambridge—found that the vaccine candidate provided a strong immune response against a range of coronaviruses by targeting the parts of the virus that are required for replication. The vaccine candidate is based on a single digitally designed and immune optimized antigen.
Tesla has been given a vote of confidence by one of the world’s wealthiest men who believes the company’s valuation could grow four to five times between now and 2030.
Investor Ron Baron was speaking to CNBC about Walter Issacson’s new biography of Elon Musk, as Business Insider summarized, and Baron discussed the stock market potential of Musk’s electric vehicle company, Tesla, among other things.
“I think Tesla in the next seven years will be about four or five times as big as it is right now in the stock market,” Baron said. “In the funds that I manage, I’ve been maxed out.”
At the meeting with Modi, Sharma presented the prime minister with a cutting-edge 5G millimeter-wave and sub-6-gigahertz chipset designed by Renesas’s R&D teams in Bengaluru and San Diego.
“The prime minister displayed a genuine fascination with the chipset and talked about the technical intricacies of the integrated chip,” the IEEE member says. “He asked about the silicon node and the fabrication facility that created it.
I firmly believe the development of these critical chips is vital for the greater public good, Sharma says. Those working in industry can be change agents and have a meaningful impact on society, such as advancing technology for humanity. After all, that is the motto of IEEE.
What makes Azobenzene molecules particularly interesting is their ability to undergo changes in their shape in response to specific types of light.
A new palm oil substitute called PALM-ALT has been developed by researchers at Queen Margaret University in Scotland. The plant-based ingredient is shown to be healthier, as well as 70% better for the environment than conventional palm oil and is described as “the holy grail to replace it.”
Food experts at Queen Margaret University (QMU) in Edinburgh have developed a new ingredient which has the potential to replace palm oil in bakery products. The new substitute is both healthier and more environmentally friendly than palm oil, which is currently used in a vast amount of baked goods. This could be a game-changing solution for the food industry, allowing manufacturers to satisfy increasing demand for tasty, lower fat, healthier products, whilst also reducing deforestation of the world’s rainforests.